Stock·NASDAQ·Consumer Defensive
Kimberly-Clark Corporation (KMB)
- Market cap
- $35.04B
- P/E
- 20.29
- Dividend yield
- 4.83%
- Street target
- $115.00median of 16 analysts
- 52-week range
- $92.42 $123.09
The short version
Where KMB stands today, in four lines, and what CleaRank Financial AI makes of it.
KMB at a glance
Kimberly-Clark Corporation (KMB): Buy, 62/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($102.87 and $102.50).
- Earnings KMB beat estimates in 6 of its last 7 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $3.3M and bought $1.0M over the last 18 months.
- Valuation P/E of 20.3 against 24.2 for the Consumer Defensive sector: broadly in line with peers (-16%).
Figures as of October 17, 2026.
CleaRank Financial AI
Kimberly-Clark Corporation (KMB) carries a CleaRank rating of Buy and a model score of 62/100.
Trend adds the most to that score, with the price 2.99% above its 200-day average, 2.63% above its 50-day average, and the 50-day average 0.36% above the 200-day. Revenue growth pulls the score down the most: revenue grew 0.60%, 4.7 percentage points slower than the sector median. The 50-day average is $102.87 and the 200-day average is $102.50, and over the past year the price fell 11.80%.
Only on CleaRank
Figures we compute ourselves from KMB's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $105.57 is 2.6% above the 50-day simple moving average of $102.87.Price above its 200-day average ›
The price is 3.0% above the 200-day simple moving average of $102.50.50-day average above the 200-day ›
The 50-day average ($102.87) is 0.4% above the 200-day average ($102.50), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 43% of its 52-week range, between $92.42 and $123.09.
KMB share price
Pick a period: each tab shows how far KMB has moved over it, to the last close.
Today's trading
Where KMB sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 20.29 is 16.2% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 2.08 is 5.3% below the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $1.7B on revenue of $16.6B, a net margin of 10.2%.Beat estimates in most recent reports ›
KMB beat the EPS estimate in 6 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 4.83%, or $5.10 a share a year.
Key statistics
The headline figures for KMB.
As of October 17, 2026, KMB trades at $105.57, with a market value of $35.04B, a P/E ratio of 20.29 and a dividend yield of 4.83%.
What the numbers say
CleaRank Financial AI's reading of KMB's valuation, growth and risks.
Kimberly-Clark Corporation (KMB) trades at 20.29 times trailing earnings, which is 16.2% below the Consumer Defensive median of 24.2. The peer comparison on this page calls that P/E broadly in line with peers. Its price-to-sales ratio of 2.08 is 5.5% below the sector median of 2.2, and its trailing earnings per share stand at $5.13.
KMB's growth lags the sector. Revenue rose 0.60% in the latest year, while the sector median is 5.3%. The company keeps a net margin of 11.79% and an operating margin of 19.00%. Return on equity, a measure of how much profit shareholders' capital generates, stands at 104.91%, which is above the sector median of 19.7%. On the balance sheet, debt-to-equity is 3.49, and the trailing dividend yield is 4.83%, equal to $5.10 a share each year.
KMB's last earnings report, on August 4, 2026, beat the estimate by 5.47%, with EPS of $2.12 versus the $2.01 analysts expected. The market agreed: the stock rose 0.72% the following session.
The earnings record shows 6 beats in 7 reports; even so, 4 of those 6 beats were followed by a lower share price the next session. The consensus EPS estimate stands at $7.38 for this fiscal year and $7.47 for next, a decline of 2.0% for the current year.
Normal swings for KMB run at about 1.57% a day. Insiders sold $3.3M over the last 18 months and bought $1.0M, though sales of this kind are often planned in advance and say less than purchases would.
KMB against the Consumer Defensive sector
How KMB compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-16% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 6, 2025, KMB has lost 20.5% against a gain of 36.6% for SPY.
Performance against SPY
KMB and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much KMB sells, and how much of it becomes profit.
Revenue growth: Revenue fell 18.0% in FY2025 to $16.4B, from $20.1B a year earlier.
Profit margin: The net margin was 12.5% in FY2025, down from 12.9% the year before.
Profitable: KMB earned $2.0B in FY2025.
Earnings reality check
Did KMB beat what analysts expected, and how did the stock react?
Earnings record: KMB beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 4, 2026after close | $2.01 | $2.12 | +5.47% | +0.72% | -2.69% |
| Oct 30, 2025after close | $1.75 | $1.82 | +4.00% | -0.42% | -16.17% |
| Aug 1, 2025after close | $1.66 | $1.92 | +15.66% | +1.91% | +4.23% |
| Apr 22, 2025after close | $1.89 | $1.93 | +2.12% | -3.28% | -5.34% |
| Jan 28, 2025after close | $1.51 | $1.50 | -0.66% | +0.18% | -0.11% |
| Oct 22, 2024after close | $1.71 | $1.83 | +7.02% | -0.62% | -2.35% |
| Jul 23, 2024after close | $1.71 | $1.96 | +14.62% | -0.66% | +0.38% |
As of October 17, 2026, KMB has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 4, 2026, came in 5.47% above the estimate and the stock moved +0.72% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 67.2, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 67.2 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of KMB
The score, the reasoning behind it, and what could move the price next.
KMB is in an uptrend. Its price of $105.57 sits 2.99% above the 200-day average of $102.50 and 2.63% above the 50-day average of $102.87. The 50-day average is 0.36% above the 200-day, so the two averages point the same way. Over the past year, the price is 14.23% above the 52-week low of $92.42 and 14.23% below the 52-week high of $123.09.
Recent gains sit against a weaker longer record: the price rose 7.61% over the past month, fell 2.57% over the past three months and fell 11.80% over the past year. The 14-day RSI of 67.2 is in the bullish zone, below the overbought line, while the MACD line is negative, so the two momentum readings point different ways.
Earnings beat ›
The August 4, 2026 report beat the EPS estimate by 5.47%, and the share price rose 0.72% in the first session after it.
Source: Earnings report, August 4, 2026
Rating reaffirmed ›
Wells Fargo kept its Equal-Weight rating on October 5, 2026.
Source: Analyst action, Wells Fargo, October 5, 2026
- Keep an eye on the two closest levels: the 52-week high of $123.09 above the price and the 50-day SMA at $102.87 below it.
- The 14-day RSI reads 67.2, in the bullish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- KMB's share price rose 0.72% in the first session after the August 4, 2026 report. Over the last 7 reports, it beat estimates in 6 of them.
KMB's uptrend depends on the price holding above its 50-day average of $102.87 and its 200-day average of $102.50. A close below the 50-day average would be the first sign of weakness. If the price pulls back, the 50-day SMA at $102.87 is the first level it would reach.
The 52-week high of $123.09 is the next level above the price. The RSI sits in the bullish zone, which means momentum still supports the upward move.
Technical indicators
Momentum and trend for KMB, from its daily closes.
As of October 17, 2026, with KMB at $105.57, its 14-day RSI is 67.2 (showing bullish momentum without being overbought), its 50-day simple moving average is $102.87 and its 200-day is $102.50.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What KMB moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, KMB's 1-year correlation of daily returns is +0.05 with S&P 500 (SPY), -0.08 with Nasdaq 100 (QQQ), -0.04 with Bitcoin (BTC) and +0.10 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
7 of 16 analysts rate it a buy or strong buy, 8 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $115.00 is 8.9% above the price.More buy ratings than three months ago ›
7 of 16 rate it a buy now, against 6 of 16 three months ago.
KMB Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Sep 25, 2026 | B of A Securities | Maintains | Buy |
| Sep 11, 2026 | Piper Sandler | Maintains | Overweight |
| Sep 10, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Aug 5, 2026 | UBS | Maintains | Neutral |
| Aug 5, 2026 | TD Cowen | Maintains | Hold |
As of October 17, 2026, 16 Wall Street analysts cover KMB: 7 rate it a buy or strong buy, 8 a hold and 1 a sell or strong sell. Their 12-month price targets range from $90.00 to $162.00, with a median of $115.00, 8.9% above the price of $105.57.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
KMB trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from KMB's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much KMB tends to move, against the market and on its own.
The long record
KMB's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.57% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 31.9%, from September 2024 to June 2026; the price is still 22.0% below that peak.Most 1-year holds ended higher ›
56% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $12,442, against $42,055 in the S&P 500 (SPY).
KMB Drawdowns & Recovery
As of October 17, 2026, KMB's worst peak-to-trough fall over the last 10 years with dividends reinvested was -31.9% (September 2024 to June 2026); it is still 22.0% below that peak, and 56% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into KMB in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: KMB trailed the S&P 500 over this period: $12,442 against $42,055.
A $10,000 investment in KMB in October 2016 would be worth about $12,442 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to KMB, and which have not.
Strongest month, April: an average of +3.95%, up in 6 of 10 years.
Weakest month, October: an average of -3.69%, up in 1 of 9 years.
This month, October: has averaged -3.69%, up in 1 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, KMB's strongest calendar month has been April (average +3.95%, up in 6 of 10 years) and its weakest October (average -3.69%, up in 1 of 9 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in KMB, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in KMB today could grow to about $12,638 by 2036 in the base case, with a 90th-percentile outcome near $30,359 and a 10th-percentile outcome around $5,261. The simulation models price only; at today's 4.83% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
KMB Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $116 for KMB by 2030 in the base case, from $106 today (1.1x over 4 years). The 10th-percentile path ends near $66.60. These are outcomes of a Monte Carlo simulation run on KMB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $81.91 | $108 | $143 | |
| 2028 | $74.76 | $111 | $164 | |
| 2029 | $70.08 | $113 | $183 | |
| 2030 | $66.60 | $116 | $202 | |
| 2031 | $63.86 | $119 | $221 |
Method: a lognormal simulation of KMB's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
KMB insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $1.0M on the open market and sold $3.3M.
As of October 17, 2026, KMB insiders reported 7 open-market sales worth $3.3M and 1 open-market purchase worth $1.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Patricia Corsi
Officer
|
Grant | 966 | - |
| Jul 31, 2026 | Craig Slavtcheff
Officer
|
Grant | 5.3K | - |
| May 6, 2026 | Andrew Scribner
Officer
|
Sell | 4.1K | $401.3K |
| May 4, 2026 | Katy Chen
Officer
|
Sell | 1.6K | $152.2K |
| May 1, 2026 | Ehab Abou-Oaf
Officer
|
Grant | 2.9K | - |
| May 1, 2026 | Katy Chen
Officer
|
Grant | 3.5K | - |
| May 1, 2026 | Patricia Corsi
Officer
|
Grant | 966 | - |
| May 1, 2026 | Tamera Fenske
Officer
|
Grant | 5.5K | - |
| May 1, 2026 | Michael D Hsu
Chief Executive Officer
|
Grant | 21.6K | - |
| May 1, 2026 | Grant B Mcgee
General Counsel
|
Grant | 2.3K | - |
| May 1, 2026 | Jeffrey P Melucci
Officer
|
Grant | 6.1K | - |
| May 1, 2026 | Andrew Scribner
Officer
|
Grant | 1.3K | - |
| May 1, 2026 | Craig Slavtcheff
Officer
|
Grant | 1.3K | - |
| May 1, 2026 | Russell Torres
President
|
Grant | 7.3K | - |
| May 1, 2026 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 6.7K | - |
| Apr 30, 2026 | Katy Chen
Officer
|
Sell | 1.4K | $136.2K |
| Apr 24, 2026 | Ehab Abou-Oaf
Officer
|
Grant | 9.2K | - |
| Apr 24, 2026 | Ehab Abou-Oaf
Officer
|
Grant | 1.6K | - |
| Apr 24, 2026 | Katy Chen
Officer
|
Grant | 823 | - |
| Apr 24, 2026 | Katy Chen
Officer
|
Grant | 3.1K | - |
| Apr 24, 2026 | Tamera Fenske
Officer
|
Grant | 10.6K | - |
| Apr 24, 2026 | Tamera Fenske
Officer
|
Grant | 1.9K | - |
| Apr 24, 2026 | Michael D Hsu
Chief Executive Officer
|
Grant | 13.5K | - |
| Apr 24, 2026 | Michael D Hsu
Chief Executive Officer
|
Grant | 76.2K | - |
| Apr 24, 2026 | Jeffrey P Melucci
Officer
|
Grant | 2.8K | - |
| Apr 24, 2026 | Jeffrey P Melucci
Officer
|
Grant | 15.5K | - |
| Apr 24, 2026 | Andrew Scribner
Officer
|
Grant | 862 | - |
| Apr 24, 2026 | Andrew Scribner
Officer
|
Grant | 3.2K | - |
| Apr 24, 2026 | Russell Torres
President
|
Grant | 3.8K | - |
| Apr 24, 2026 | Russell Torres
President
|
Grant | 21.2K | - |
| Apr 24, 2026 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 3.4K | - |
| Apr 24, 2026 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 19.1K | - |
| Feb 9, 2026 | Samuel Todd Maclin
Director
|
Buy | 10.0K | $1.0M |
| Feb 5, 2026 | Andrew Scribner
Officer
|
Sell | 3.0K | $318.0K |
| Jan 30, 2026 | Grant B Mcgee
General Counsel
|
Grant | 3.5K | - |
| Jan 30, 2026 | Jeffrey P Melucci
Officer
|
Grant | 4.5K | - |
| Oct 31, 2025 | Tamera Fenske
Officer
|
Grant | 20.2K | - |
| Oct 31, 2025 | Tamera Fenske
Officer
|
Grant | 4.5K | - |
| Aug 4, 2025 | Zackery Allen Hicks
Chief Technology Officer
|
Sell | 15.0K | $2.0M |
| Jul 31, 2025 | Patricia Corsi
Officer
|
Grant | 921 | - |
| Jul 31, 2025 | Craig Slavtcheff
Officer
|
Grant | 5.0K | - |
| Jul 29, 2025 | Zackery Allen Hicks
Chief Technology Officer
|
Grant | 38.1K | - |
| Jul 29, 2025 | Zackery Allen Hicks
Chief Technology Officer
|
Grant | 5.4K | - |
| May 2, 2025 | Katy Chen
Officer
|
Sell | 740 | $96.0K |
| May 1, 2025 | Ehab Abou-Oaf
Officer
|
Grant | 1.4K | - |
| May 1, 2025 | Katy Chen
Officer
|
Grant | 1.6K | - |
| May 1, 2025 | Andrew Cpa Drexler
Officer
|
Grant | 654 | - |
| May 1, 2025 | Tamera Fenske
Officer
|
Grant | 1.4K | - |
| May 1, 2025 | Zackery Allen Hicks
Chief Technology Officer
|
Grant | 2.7K | - |
| May 1, 2025 | Michael D Hsu
Chief Executive Officer
|
Grant | 10.0K | - |
| May 1, 2025 | Sandra R A Karrmann
Officer
|
Grant | 1.1K | - |
| May 1, 2025 | Grant B Mcgee
General Counsel
|
Grant | 1.1K | - |
| May 1, 2025 | Jeffrey P Melucci
Officer
|
Grant | 2.9K | - |
| May 1, 2025 | Russell Torres
Officer
|
Grant | 3.0K | - |
| May 1, 2025 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 3.2K | - |
| Apr 29, 2025 | Katy Chen
Officer
|
Sell | 1.8K | $234.5K |
| Apr 25, 2025 | Ehab Abou-Oaf
Officer
|
Grant | 1.2K | - |
| Apr 25, 2025 | Katy Chen
Officer
|
Grant | 1.1K | - |
| Apr 25, 2025 | Katy Chen
Officer
|
Grant | 2.8K | - |
| Apr 25, 2025 | Andrew S Drexler
Officer
|
Grant | 1.8K | - |
| Apr 25, 2025 | Tamera Fenske
Officer
|
Grant | 1.3K | - |
| Apr 25, 2025 | Zackery Allen Hicks
Officer
|
Grant | 2.7K | - |
| Apr 25, 2025 | Michael D Hsu
Chief Executive Officer
|
Grant | 9.7K | - |
| Apr 25, 2025 | Sandra R A Karrmann
Officer
|
Grant | 1.1K | - |
| Apr 25, 2025 | Jeffrey P Melucci
Officer
|
Grant | 2.0K | - |
| Apr 25, 2025 | Russell Torres
Officer
|
Grant | 2.7K | - |
| Apr 25, 2025 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 26.4K | - |
| Apr 25, 2025 | Nelson Urdaneta
Chief Financial Officer
|
Grant | 2.4K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.